{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:47:59Z","timestamp":1782128879667,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49259-8","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:53:25Z","timestamp":1777182805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting immunohistochemical expression status and molecular subtypes using synthetic magnetic resonance imaging and multiple multiplexed sensitivity encoding diffusion weighted imaging in breast cancer: a prospective study"],"prefix":"10.1038","volume":"16","author":[{"given":"Lei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"49259_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","volume":"12","author":"D Zardavas","year":"2015","unstructured":"Zardavas, D., Irrthum, A., Swanton, C. & Piccart, M. Clinical management of breast cancer heterogeneity. Nat. Rev. Clin. Oncol. 12, 381\u2013394 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"49259_CR2","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates, A. S. et al. Tailoring therapies\u2014improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann. Oncol. 26, 1533\u20131546 (2015).","journal-title":"Ann. Oncol."},{"issue":"14","key":"49259_CR3","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1200\/JCO.2007.13.6580","volume":"26","author":"MP DiGiovanna","year":"2008","unstructured":"DiGiovanna, M. P. et al. Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: Study 8541 from the Cancer and Leukemia Group B. J. Clin. Oncol. 26(14), 2364\u20132372 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"49259_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch, A. et al. Strategies for subtypes\u2013dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.. Ann. Oncol. 22(8), 1736\u20131747 (2011).","journal-title":"Ann. Oncol."},{"issue":"2","key":"49259_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1148\/radiol.14140645","volume":"274","author":"K Strobel","year":"2026","unstructured":"Strobel, K., Schrading, S., Hansen, N. L., Barabasch, A. & Kuhl, C. K. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging. Radiology 274(2), 343\u2013351 (2026).","journal-title":"Radiology"},{"issue":"2","key":"49259_CR6","first-page":"343","volume":"10","author":"W Wang","year":"2026","unstructured":"Wang, W. et al. Comparison of MUSE-DWI and conventional DWI in the application of invasive breast cancer and malignancy grade prediction: A comparative study. Heliyon 10(2), (2026).","journal-title":"Heliyon"},{"issue":"1119","key":"49259_CR7","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200427","volume":"94","author":"GC Baxter","year":"2021","unstructured":"Baxter, G. C. et al. Improving the image quality of DWI in breast cancer: Comparison of multi-shot DWI using multiplexed sensitivity encoding to conventional single-shot echo-planar imaging DWI. Br. J. Radiol. 94(1119), 20200427 (2021).","journal-title":"Br. J. Radiol."},{"key":"49259_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mri.2022.01.003","volume":"87","author":"J Johansson","year":"2022","unstructured":"Johansson, J. et al. Brain diffusion MRI with multiplexed sensitivity encoding for reduced distortion in a pediatric patient population. Magn. Reson. Imaging 87, 97\u2013103 (2022).","journal-title":"Magn. Reson. Imaging"},{"issue":"1","key":"49259_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jmri.27801","volume":"55","author":"H Chang","year":"2022","unstructured":"Chang, H. et al. Multi-shot Diffusion-Weighted MRI With Multiplexed Sensitivity Encoding (MUSE) in the assessment of active inflammation in Crohn\u2019s Disease. J. Magn. Reson. Imaging 55(1), 126\u2013137 (2022).","journal-title":"J. Magn. Reson. Imaging"},{"key":"49259_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109292","volume":"132","author":"Y-Y Kim","year":"2020","unstructured":"Kim, Y.-Y., Kim, M.-J., Gho, S.-M. & Seo, N. Comparison of multiplexed sensitivity encoding and single-shot echo-planar imaging for diffusion-weighted imaging of the liver. Eur. J. Radiol. 132, 109292 (2020).","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"49259_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6298-5","volume":"19","author":"A Surov","year":"2019","unstructured":"Surov, A. et al. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: A multicenter analysis. BMC Cancer 19(1), 1043 (2019).","journal-title":"BMC Cancer"},{"issue":"4","key":"49259_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-019-1197-5","volume":"43","author":"C Yuan","year":"2019","unstructured":"Yuan, C. et al. Correlation analysis of breast cancer DWI combined with DCE-MRI imaging features with molecular subtypes and prognostic factors. J. Med. Syst. 43(4), 83 (2019).","journal-title":"J. Med. Syst."},{"issue":"3","key":"49259_CR13","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/jmri.26697","volume":"50","author":"JV Horvat","year":"2019","unstructured":"Horvat, J. V. et al. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer. J. Magn. Reson. Imaging 50(3), 836\u2013846 (2019).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"49259_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/jmri.22400","volume":"33","author":"SK Jeh","year":"2011","unstructured":"Jeh, S. K. et al. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J. Magn. Reson. Imaging 33(1), 102\u2013109 (2011).","journal-title":"J. Magn. Reson. Imaging"},{"issue":"2","key":"49259_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mrm.21635","volume":"60","author":"JBM Warntjes","year":"2008","unstructured":"Warntjes, J. B. M., Leinhard, O. D., West, J. & Lundberg, P. Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn. Reson. Med. 60(2), 320\u2013329 (2008).","journal-title":"Magn. Reson. Med."},{"issue":"1093","key":"49259_CR16","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20180479","volume":"92","author":"Y Jung","year":"2019","unstructured":"Jung, Y. et al. The feasibility of synthetic MRI in breast cancer patients: Comparison of T2 relaxation time with multiecho spin echo T2 mapping method. Br. J. Radiol. 92(1093), 20180479 (2019).","journal-title":"Br. J. Radiol."},{"issue":"5","key":"49259_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/2058460118769686","volume":"7","author":"S Boudabbous","year":"2018","unstructured":"Boudabbous, S. et al. Feasibility of synthetic MRI in knee imaging in routine practice. Acta Radiol. Open 7(5), 2058460118769686 (2018).","journal-title":"Acta Radiol. Open"},{"issue":"10","key":"49259_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/RLI.0000000000000365","volume":"52","author":"A Hagiwara","year":"2017","unstructured":"Hagiwara, A. et al. SyMRI of the brain: Rapid quantification of relaxation rates and proton density, with synthetic MRI, automatic brain segmentation, and myelin measurement. Invest. Radiol. 52(10), 647\u2013657 (2017).","journal-title":"Invest. Radiol."},{"issue":"10","key":"49259_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/RLI.0000000000000579","volume":"54","author":"Y Arita","year":"2019","unstructured":"Arita, Y. et al. Quantitative assessment of bone metastasis in prostate cancer using synthetic magnetic resonance imaging. Invest. Radiol. 54(10), 638\u2013644 (2019).","journal-title":"Invest. Radiol."},{"issue":"1","key":"49259_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00330-022-09027-4","volume":"33","author":"P Wang","year":"2022","unstructured":"Wang, P. et al. Synthetic MRI in differentiating benign from metastatic retropharyngeal lymph node: Combination with diffusion-weighted imaging. Eur. Radiol. 33(1), 152\u2013161 (2022).","journal-title":"Eur. Radiol."},{"issue":"1","key":"49259_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00365-4","volume":"20","author":"T Meng","year":"2020","unstructured":"Meng, T. et al. The diagnostic performance of quantitative mapping in breast cancer patients: A preliminary study using synthetic MRI. Cancer Imaging 20(1), 88 (2020).","journal-title":"Cancer Imaging"},{"issue":"2","key":"49259_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jmri.27362","volume":"53","author":"M Matsuda","year":"2021","unstructured":"Matsuda, M. et al. Enhanced masses on contrast-enhanced breast: Differentiation using a combination of dynamic contrast-enhanced MRI and quantitative evaluation with synthetic MRI. J. Magn. Reson. Imaging 53(2), 381\u2013391 (2021).","journal-title":"J. Magn. Reson. Imaging"},{"key":"49259_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1180131","volume":"13","author":"H He","year":"2024","unstructured":"He, H. et al. Multiparametric MRI model with synthetic MRI, DWI multi-quantitative parameters, and differential sub-sampling with cartesian ordering enables BI-RADS 4 lesions diagnosis with high accuracy. Front. Oncol. 13, 1180131 (2024).","journal-title":"Front. Oncol."},{"key":"49259_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1080580","volume":"12","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination. Front. Oncol. 12, 1080580 (2023).","journal-title":"Front. Oncol."},{"issue":"3","key":"49259_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.mric.2013.02.005","volume":"21","author":"SD Edwards","year":"2026","unstructured":"Edwards, S. D., Lipson, J. A., Ikeda, D. M. & Lee, J. M. Updates and revisions to the BI-RADS magnetic resonance imaging lexicon. Magn. Reson. Imaging Clin. North. Am. 21(3), 483\u2013493 (85AD).","journal-title":"Magn. Reson. Imaging Clin. North. Am."},{"issue":"7","key":"49259_CR26","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.5858\/134.7.e48","volume":"134","author":"MEH Hammond","year":"2026","unstructured":"Hammond, M. E. H. et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 134(7), e48\u2013e72 (2026).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"20","key":"49259_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2026","unstructured":"Wolff, A. C. et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J. Clin. Oncol. 36(20), 2105\u20132122.","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"49259_CR28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jmri.28683","volume":"58","author":"M Amano","year":"2026","unstructured":"Amano, M. et al. Feasibility of quantitative MRI using 3D-QALAS for discriminating immunohistochemical status in invasive ductal carcinoma of the breast. J. Magn. Reson. Imaging: JMRI 58(6), 1752\u20131759.","journal-title":"J. Magn. Reson. Imaging: JMRI"},{"key":"49259_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.mri.2020.12.001","volume":"77","author":"S Du","year":"2021","unstructured":"Du, S. et al. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI. Magn. Reson. Imaging 77, 148\u2013158 (2021).","journal-title":"Magn. Reson. Imaging"},{"key":"49259_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110168","volume":"148","author":"W Gao","year":"2022","unstructured":"Gao, W. et al. Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer. Eur. J. Radiol. 148, 110168 (2022).","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"49259_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/life12091307","volume":"12","author":"T Kazama","year":"2022","unstructured":"Kazama, T. et al. Quantitative values from synthetic MRI correlate with breast cancer subtypes. Life 12(9), 1307 (2022).","journal-title":"Life"},{"issue":"1","key":"49259_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45079-2","volume":"13","author":"X Li","year":"2023","unstructured":"Li, X. et al. Synthetic MRI in breast cancer: Differentiating benign from malignant lesions and predicting immunohistochemical expression status. Sci. Rep. 13(1), 17978 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"49259_CR33","doi-asserted-by":"publisher","first-page":"398.e1","DOI":"10.1016\/j.crad.2019.12.021","volume":"75","author":"M Matsuda","year":"2020","unstructured":"Matsuda, M. et al. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: A feasibility study. Clin. Radiol. 75(5), 398.e1-398.e8 (2020).","journal-title":"Clin. Radiol."},{"key":"49259_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6746326","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Hao, J., Guo, J., Zhao, X. & Yin, X. Predicting of Ki-67 expression level using diffusion-weighted and synthetic magnetic resonance imaging in invasive ductal breast cancer. Breast J. https:\/\/doi.org\/10.1155\/2023\/6746326 (2023).","journal-title":"Breast J."},{"issue":"1016","key":"49259_CR35","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1259\/bjr\/79381464","volume":"85","author":"SY Choi","year":"2012","unstructured":"Choi, S. Y. et al. Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br. J. Radiol. 85(1016), e474\u2013e479 (2012).","journal-title":"Br. J. Radiol."},{"issue":"10","key":"49259_CR36","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/annonc\/mdp062","volume":"20","author":"BK Linderholm","year":"2009","unstructured":"Linderholm, B. K. et al. Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann. Oncol. 20(10), 1639\u20131646 (2009).","journal-title":"Ann. Oncol."},{"issue":"6","key":"49259_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/modpathol.2011.4","volume":"24","author":"RAA Mohammed","year":"2011","unstructured":"Mohammed, R. A. A. et al. Lymphatic and blood vessels in basal and triple-negative breast cancers: Characteristics and prognostic significance. Mod. Pathol. 24(6), 774\u2013785 (2011).","journal-title":"Mod. Pathol."},{"key":"49259_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109838","volume":"142","author":"T Tsuda","year":"2021","unstructured":"Tsuda, T. et al. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma. Eur. J. Radiol. 142, 109838 (2021).","journal-title":"Eur. J. Radiol."},{"issue":"2","key":"49259_CR39","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.crad.2023.10.015","volume":"79","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Pretreatment synthetic MRI features for triple-negative breast cancer. Clin. Radiol. 79(2), e219\u2013e226 (2024).","journal-title":"Clin. Radiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49259-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:03:08Z","timestamp":1782126188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49259"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49259-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7105718\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19239"}}